Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
MRTX | Mirati Therapeutics, Inc. | Chief Financial Officer | $6.04M | Aug 9, 2023 | ||
ARNA | ARENA PHARMACEUTICALS INC | EVP & Chief Financial Officer | Mar 11, 2022 | |||
PMVP | PMV Pharmaceuticals, Inc. | Director | Jun 6, 2024 | |||
SYRE | Spyre Therapeutics, Inc. | Director | May 14, 2024 | |||
SURF | Surface Oncology, Inc. | Director | Jun 8, 2022 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|